# EDGAR Filing Document

**Accession Number:** 0001325618
**File Stem:** 0000000000-25-008843
**Filing Date:** 2025-8
**Character Count:** 3456
**Document Hash:** cead8cf75348b69737609f680f1d0d89
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-25-008843.hdr.sgml**: 20260122

**ACCESSION NUMBER**: 0000000000-25-008843

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250820

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** IRADIMED CORP
- **CENTRAL INDEX KEY:** 0001325618
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 731408526
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 001-36534

**BUSINESS ADDRESS:**
- **STREET 1:** 12705 INGENUITY DRIVE
- **CITY:** ORLANDO
- **STATE:** FL
- **ZIP:** 32826
- **BUSINESS PHONE:** 4076778022

**MAIL ADDRESS:**
- **STREET 1:** 12705 INGENUITY DRIVE
- **CITY:** ORLANDO
- **STATE:** FL
- **ZIP:** 32826
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001558370-25-002389

## Text-Extract

```

                                                            August 20, 2025

John Glenn
Chief Financial Officer
IRADIMED CORP
1025 Willa Springs Drive
Winter Springs, Florida 32708

       Re: IRADIMED CORP
           Form 10-K for the Year Ended December 31, 2024
           File No. 001-36534
Dear John Glenn:

       We have reviewed your filing and have the following comments.

       Please respond to this letter within ten business days by providing the
requested
information or advise us as soon as possible when you will respond. If you do
not believe a
comment applies to your facts and circumstances, please tell us why in your
response.

       After reviewing your response to this letter, we may have additional
comments.

Form 10-K for the Year Ended December 31, 2024
Exhibit 32.1

1.     We note that the Section 906 certifications required by Rule 13-a14(b)
of the
       Exchange Act have been omitted from your Form 10-K. Please file an
amended Form
       10-K in its entirety and include the certifications as Exhibits as
required by Item 601
       of Regulation S-K.
Warranty, page F-12

2.     Given the materiality of your extended warranty products to your
earnings and total
       liabilities, it is not clear why the tabular disclosure referenced in
ASC 460-10-50-8
       has been omitted. Please provide for us a schedule of activity in your
warranty reserve
       covering the 2023 and 2024 annual periods. Also, if your extended
warranty products
       have had a disproportionate impact on your consolidated gross margin
then that fact
       should be disclosed in MD&A. See Item 303(b)(2)(i) of Regulation S-K.
        We remind you that the company and its management are responsible for
the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action
or absence
of action by the staff.
 August 20, 2025
Page 2

       Please contact Nudrat Salik at 202-551-3692 or Al Pavot at 202-551-3738
if you have
questions regarding comments on the financial statements and related matters.

                                                         Sincerely,

                                                         Division of
Corporation Finance
                                                         Office of Industrial
Applications and
                                                         Services

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._